ECNP Podcast 1 — more information
Interviewed: David Nutt, United Kingdom
David Nutt, DM, FRCP, FRCPsych, FMedSci, DLaws, is a psychiatrist and the Edmund J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept of Medicine, Hammersmith Hospital, Imperial College London. To study the effects of drugs in the brain he uses state of the art techniques such as brain imaging with PET and fMRI plus EEG and MEG. This research output has led to over 500 original research papers outs him in the top 0.1% of researchers in the world. He has also published a similar number of reviews and books chapters, eight government reports on drugs and 35 books, including one for the general public, Drugs: without the hot air, that won the Transmission Prize in 2014. He was previously President of the European Brain Council, the British Association of Psychopharmacology, the British Neuroscience Association and the European College of Neuropsychopharmacology. He is currently Founding Chair of DrugScience.org.uk and holds visiting Professorships at the Open University and University of Maastricht. David broadcasts widely to the general public both on radio and television. In 2010 The Times Eureka science magazine voted him one of the 100 most important figures in British Science, and the only psychiatrist in the list. In 2013 he was awarded the John Maddox Prize from Nature/Sense about Science for standing up for science and in 2017 a Doctor of Laws hon causa from the University of Bath.
Interviewer: Aiste Lengvenyte, Lithuania
Aiste Lengvenyte is a psychiatrist working as Chef de Clinique et Assistant des Hopitaux in Montpellier, France. She studied medicine in Lithuanian University of Health Sciencies, Lithuania, and later completed her training in psychiatry in Vilnius University, Lithuania. During her studies, she has spent time in Cagliari, Italy, Montpellier, France, and London, United Kingdom. Concurrently with her clinical work, she is undertaking a PhD project on suicidal behaviours. She is interested in biological bases of suicidal behaviours and mood disorders, as well as the best ways to address these issues. Since 2019 she is a member of ECNP’s Early Career Advisory Panel (ECAP).